We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




ResearchDx Completes Service Offerings by Partnering with CompanDX

By LabMedica International staff writers
Posted on 22 Jun 2011
ResearchDx (Irvine, CA, USA) is partnering with CompanDX (Nottingham, United Kingdom) to discover and deliver novel molecular diagnostic tests for clients in the healthcare setting.

CompanDX uses its Distiller platform to deliver small composite biomarker signatures from complex data of high dimensionality, which are commonplace in clinical development of therapeutics. More...
ResearchDx designs, produces and validates tests ready for the market and offers turnkey solutions for companion diagnostic delivery.

The new partnership will enable clients to initiate the development of companion diagnostic tests from the earliest stages of drug development. CompanDX has developed a set of tools to deliver an understanding of the mechanism of action and biomarkers that describe patient response.

ResearchDx is a Contract Diagnostics Organization (CDO) for the diagnostic and biopharmaceutic industries. The company's primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. ResearchDx offers CLIA certified, CAP accredited high-complexity testing through its subsidiary, Pacific Diagnostics. It provides a full complement of cytogenetics, Fluorescence in situ hybridization (FISH), molecular and specialty services.

"Our partnership with CompanDX completes our service offerings," said founders of ResearchDx Dr. Philip Cotter and Dr. Mathew Moore. "CompanDX's unique capabilities allow us to fully integrate bioinformatics into development of a diagnostic product from early in the discovery process. Our customers can trust ResearchDx to meet scientific challenges with a focus on their business priorities."

Related Links:

ResearchDx
CompanDX



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.